E Prescription Systems with Medication Continuity in Primary Care Practices: Survey Analysis
Keywords:
Electronic Prescribing, Medication Continuity, Primary Care Informatics, Health Information Technology, E Prescription SystemsAbstract
Electronic prescribing (e-prescribing) systems have become an essential pillar of modern clinical practice, replacing paper-based ordering workflows with digital transmission pathways to improve patient safety, reduce medication errors, and streamline clinical operations. While the adoption of electronic prescribing has expanded rapidly, its direct influence on long-term medication continuity and clinical adherence in primary care practices remains highly complex and variable. This study conducts a comprehensive survey analysis of primary care practitioners to examine how specific e-prescription system features, usability profiles, and inter-organizational communication capabilities correlate with medication continuity. Surveying physicians, nurse practitioners, physician assistants, and administrative staff across diverse primary care settings, we evaluate the implementation and utilization rates of core digital prescribing functions. The findings indicate that while basic transmission capabilities are nearly universal, substantial barriers exist regarding system interoperability, formulary verification accuracy, and clinical alert fatigue. Multivariate regression analysis shows that features such as automated electronic refill authorization and secure bidirectional messaging with retail pharmacies are significant positive predictors of reported medication continuity. Conversely, poorly calibrated clinical decision support alerts frequently lead to alert overrides, undermining the safety advantages of electronic platforms. The study concludes with practical recommendations for software vendors, clinical administrators, and policymakers to optimize system usability, reduce cognitive burden, and establish robust, closed-loop communications that support sustained patient adherence and continuity of care.References
1. Tan, M.L.; Zhao, P.; Zhang, L.; Ho, Y.F.; Varma, M.V.S.; Neuhoff, S.; Nolin, T.D.; Galetin, A.; Huang, S.M. Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates. Clin. Pharmacol. Ther. 2019, 105, 719–729.
2. Silva, J.Q.D.; Moraes, N.V.; Estrela, R.; Coelho, D., Jr.; Feriani, D.; Migotto, K.; Caruso, P.; Silva, I.; Oliveira, D.A.; Telles, J.P.; et al. Amikacin Dosing Adjustment in Critically Ill Oncologic Patients: A Study with Real-World Patients, PBPK Analysis, and Digital Twins. Pharmaceutics 2025, 17, 297.
3. Pelc, Z.; Skorzewska, M.; Kurylcio, A.; Olko, P.; Dryka, J.; Machowiec, P.; Maksymowicz, M.; Rawicz-Pruszyński, K.; Polkowski, W. Current Challenges in Breast Implantation. Medicina 2021, 57, 1214.
4. Darwich, A.S.; Polasek, T.M.; Aronson, J.K.; Ogungbenro, K.; Wright, D.F.B.; Achour, B.; Reny, J.L.; Daali, Y.; Eiermann, B.; Cook, J.; et al. Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy. Annu. Rev. Pharmacol. Toxicol. 2021, 61, 225–245.
5. Maharaj, A.R.; Wu, H.; Hornik, C.P.; Arrieta, A.; James, L.; Bhatt-Mehta, V.; Bradley, J.; Muller, W.J.; Al-Uzri, A.; Downes, K.J.; et al. Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacy. J. Pharmacokinet. Pharmacodyn. 2020, 47, 199–218.
6. Soulsby, C.T.; Khela, M.; Yazaki, E.; Evans, D.F.; Hennessy, E.; Powell-Tuck, J. Measurements of gastric emptying during continuous nasogastric infusion of liquid feed: Electric impedance tomography versus gamma scintigraphy. Clin. Nutr. 2006, 25, 671–680.
7. Basher, A.; Moniruzzaman, M.; Islam, M.M.; Rashid, M.M.; Chowdhury, I.H.; Akm, A.; Rabbani, K.S. Evaluation of gastric emptying in critically ill patients using electrical impedance method: A pilot study. J. Med. Eng. Technol. 2022, 46, 363–369.
8. Zhang, Y.; Ye, J.; Jiao, Y.; Zhang, W.; Zhang, T.; Tian, X.; Shi, X.; Fu, F.; Wang, L.; Xu, C. A pilot study of contrast-enhanced electrical impedance tomography for real-time imaging of cerebral perfusion. Front. Neurosci. 2022, 16, 1027948. [ Central]
9. Yang, B.; Li, B.; Xu, C.; Hu, S.; Dai, M.; Xia, J.; Luo, P.; Shi, X.; Zhao, Z.; Dong, X.; et al. Comparison of electrical impedance tomography and intracranial pressure during dehydration treatment of cerebral edema. Neuroimage Clin. 2019, 23, 101909.
10. Edwards, M.C.; Gabriel, A.; Hammer, J.; Jewell, H.L.; Jewell, M.L. Gel Cohesivity and Breast Augmentation: Applications to Clinical Practice. Aesthetic Surg. J. Open Forum 2022, 4, ojac088.
11. Domínguez-Romero, E.; Mazurenko, S.; Scheringer, M.; Martins dos Santos, V.A.P.; Evelo, C.T.; Anton, M.; Hancock, J.M.; Županič, A.; Suarez-Diez, M. Making PBPK models more reproducible in practice. Brief. Bioinform. 2024, 25, bbae569.
12. Iwashita, Y.; Takeda, S.; Kawashima, S.; Koshi, T.; Nomura, K.I.; Sato, S.; Sato, R.; Yamada, N.; Nebuya, S. A Clinical Case of Three-Dimensional Electrical Impedance Tomography (3D-EIT) Measurements. Cureus 2024, 16, e73291. [ Central]
13. Nebuya, S.; Kumagai, H.; Suzuki, H. Image generation apparatus, conductivity acquisition apparatus, image generation method, and program. U.S. Patent 11534076B2, 25 February 2014.
14. Van Ravenzwaaij, D.; Ioannidis, J.P. A simulation study of the strength of evidence in the recommendation of medications based on two trials with statistically significant results. PLoS ONE 2017, 12, e0173184.
15. Lakens, D. The Practical Alternative to the p Value Is the Correctly Used p Value. Perspect. Psychol. Sci. 2021, 16, 639–648.
16. Jiang, Y.D.; Soleimani, M. Capacitively Coupled Electrical Impedance Tomography for Brain Imaging. IEEE Trans. Med. Imaging 2019, 38, 2104–2113.
17. Li, Y.H.; Xu, J.H.; Yang, J.J.; Tian, J.; Xu, J.G. Predictive performance of ‘Diprifusor’ TCI system in patients during upper abdominal surgery under propofol/fentanyl anesthesia. J. Zhejiang Univ. Sci. B 2005, 6, 43–48.
18. Greenland, S. Bayesian perspectives for epidemiological research: I. Foundations and basic methods. Int. J. Epidemiol. 2006, 35, 765–775.
19. Khalil, F.; Läer, S. Physiologically based pharmacokinetic modeling: Methodology, applications, and limitations with a focus on its role in pediatric drug development. J. Biomed. Biotechnol. 2011, 2011, 907461.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), unless otherwise stated.